Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of simvastatin suspoemulsion and its preparation method and application

A simvastatin and suspension technology, which is applied in the field of simvastatin suspoemulsion and its preparation, can solve the problems of inability to meet factory production and clinical drug use, poor drug absorption, low effective drug dose, etc. Bioavailability, broad clinical application prospects, and the effect of no antibiotic residues

Active Publication Date: 2022-04-22
黑龙江省农业科学院畜牧兽医分院
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the good lipophilicity and poor hydrophilicity of simvastatin, the current Pharmacopoeia is limited to tablets and capsules, and its effective dose is low. However, its original powder is directly made into water-soluble injection for intramuscular injection of animals. High toxicity, poor drug absorption, easy to cause adverse reactions, can not meet the needs of factory production and clinical medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] The preparation method of simvastatin suspoemulsion specifically adopts the following process:

[0022] Add the sustained-release agent to part of the water for injection, stir and heat at 60-80°C until it melts to form a stable prepolymer solution, then add simvastatin to the prepolymer solution, and fully shear and stir to disperse until it becomes very fine. Continue heating at 60-80°C until the particles form microcapsules, then add emulsifiers, surfactants, antioxidants, preservatives and the rest of water and stir evenly to obtain the simvastatin mixture of the present invention. Suspoemulsion.

Embodiment 2

[0024] Using the preparation process of Example 1, based on the preparation amount of 1L of medicine, the specific raw materials and components are as follows:

[0025] Simvastatin 50mL, sodium lauryl sulfate 10mL, monoglyceride laurate 20mL, sodium alginate 60mL, SOD 5mL and trichlorobutanol 0.05mL, the balance is water for injection.

Embodiment 3

[0027] Using the preparation process of Example 1, based on the preparation amount of 1L of medicine, the specific raw materials and components are as follows:

[0028] Simvastatin 100mL, stearic acid 30mL, lauryl polyoxyethylene ether 25mL, carboxymethylcellulose sodium 62mL, CAT 5mL and sodium benzoate 0.05mL, the balance is water for injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a simvastatin suspension emulsion and its preparation method and application. Combining the pharmaceutical properties of simvastatin with the preparation process of microcapsule preparations, simvastatin is first prepared into a microcapsule structure with sustained release function, and then mixed with other additives to prepare a suspoemulsion, in which surfactants and emulsifiers make it It has the advantages of both suspension and emulsion, increases the effective dose of simvastatin in the carrier, quickly reaches the target organ after intramuscular injection, maintains the effective blood concentration of the target organ for a long time, and the sustained release function of the microcapsule structure prolongs the half-life of the drug. Improve drug bioavailability, reduce the number of administration, reduce drug side effects, the most important thing is no antibiotic residues, has broad clinical application prospects.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a simvastatin suspension emulsion and its preparation method and application. Background technique [0002] Mastitis is one of the three major diseases that endanger the health of dairy cows. The number of somatic cells in affected cows increases, and the milk production and milk quality decrease. In the past treatment, antibiotics were often used, but improper application and abuse of antibiotics will not only cause milk Drug residues affect milk quality, and can also cause a large number of drug-resistant strains, resulting in failure of follow-up treatment and endangering the health of dairy users. [0003] In the prior art, most of the alternatives to antibiotic treatment methods are traditional Chinese medicine prescriptions, improved Chinese medicine prescriptions, and the development of mastitis vaccines and yolk antibodies to prevent diseases. However, due to the ineffe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/107A61K9/52A61K31/366A61K47/20A61K47/14A61K47/12A61K47/10A61K47/36A61K47/38A61P15/14
CPCA61K9/107A61K9/0019A61K9/5036A61K9/5047A61K31/366A61K47/20A61K47/14A61K47/12A61K47/10A61P15/14
Inventor 冯万宇王岩陈亮武晓东张艳张晓玲郝淑娟张会新
Owner 黑龙江省农业科学院畜牧兽医分院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products